111 related articles for article (PubMed ID: 9616526)
1. The effect of oral corticosteroids on bronchodilator responses in COPD.
Corden Z; Rees PJ
Respir Med; 1998 Feb; 92(2):279-82. PubMed ID: 9616526
[TBL] [Abstract][Full Text] [Related]
2. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
[TBL] [Abstract][Full Text] [Related]
3. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.
Cazzola M; Matera MG; Di Perna F; Calderaro F; Califano C; Vinciguerra A
Respir Med; 1998 Feb; 92(2):354-7. PubMed ID: 9616538
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.
Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367
[TBL] [Abstract][Full Text] [Related]
5. Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease.
Davies L; Nisar M; Pearson MG; Costello RW; Earis JE; Calverley PM
QJM; 1999 Jul; 92(7):395-400. PubMed ID: 10627889
[TBL] [Abstract][Full Text] [Related]
6. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.
Frith PA; Jenner B; Dangerfield R; Atkinson J; Drennan C
Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
9. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
10. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
Cazzola M; Matera MG; Di Perna E; Califano C; D'Amato M; Mazzarella G
Respir Med; 1999 Dec; 93(12):909-11. PubMed ID: 10653054
[TBL] [Abstract][Full Text] [Related]
11. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
Cazzola M; Di Perna F; Centanni S; Califano C; Donner CF; D'Amato M; D'Amato G
Thorax; 1999 Dec; 54(12):1083-6. PubMed ID: 10567627
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma.
Nishi K; Fujimura M; Myou S; Ooka T; Sakamoto S; Saitou M; Kasahara K; Matsuda T
Clin Auton Res; 1993 Feb; 3(1):41-4. PubMed ID: 8477180
[TBL] [Abstract][Full Text] [Related]
13. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
[TBL] [Abstract][Full Text] [Related]
14. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial).
Bellia V; Foresi A; Bianco S; Grassi V; Olivieri D; Bensi G; Volonté M;
Respir Med; 2002 Nov; 96(11):881-9. PubMed ID: 12418585
[TBL] [Abstract][Full Text] [Related]
16. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
[TBL] [Abstract][Full Text] [Related]
17. Acute bronchodilator trials in chronic obstructive pulmonary disease.
Nisar M; Earis JE; Pearson MG; Calverley PM
Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
[TBL] [Abstract][Full Text] [Related]
18. Oxitropium bromide improves exercise performance in patients with COPD.
Ikeda A; Nishimura K; Koyama H; Sugiura N; Izumi T
Chest; 1994 Dec; 106(6):1740-5. PubMed ID: 7988193
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease.
Koyama H; Nishimura K; Ikeda A; Izumi T
Chest; 1993 Dec; 104(6):1743-7. PubMed ID: 8252955
[TBL] [Abstract][Full Text] [Related]
20. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD.
Di Marco F; Milic-Emili J; Boveri B; Carlucci P; Santus P; Casanova F; Cazzola M; Centanni S
Eur Respir J; 2003 Jan; 21(1):86-94. PubMed ID: 12570114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
